Daniel Markowitz

Stock Analyst at Evercore ISI Group

(4.44)
# 482
Out of 5,127 analysts
22
Total ratings
76.47%
Success rate
14.42%
Average return

Stocks Rated by Daniel Markowitz

Bio-Techne
Jan 5, 2026
Downgrades: In-Line
Price Target: $68$62
Current: $64.58
Upside: -4.00%
Guardant Health
Jan 5, 2026
Downgrades: In-Line
Price Target: $90$105
Current: $108.74
Upside: -3.44%
Insulet
Dec 16, 2025
Initiates: Outperform
Price Target: $370
Current: $292.89
Upside: +26.33%
DexCom
Nov 25, 2025
Initiates: In-Line
Price Target: $68
Current: $68.43
Upside: -0.63%
Natera
Nov 7, 2025
Maintains: Outperform
Price Target: $190$250
Current: $239.56
Upside: +4.36%
Rambus
Oct 28, 2025
Maintains: Outperform
Price Target: $114$126
Current: $91.34
Upside: +37.95%
West Pharmaceutical Services
Oct 23, 2025
Maintains: Outperform
Price Target: $350$390
Current: $275.23
Upside: +41.70%
Repligen
Oct 7, 2025
Maintains: Outperform
Price Target: $155$175
Current: $166.42
Upside: +5.16%
Inspire Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $150$125
Current: $95.00
Upside: +31.58%
TransMedics Group
Sep 16, 2025
Initiates: Outperform
Price Target: $155
Current: $137.57
Upside: +12.67%